Home › Atherosclerosis › New York
Atherosclerosis clinical trials in New York
9 studies for Atherosclerosis are looking for participants at sites in New York.
Cities in New York
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- DiGiovanna Inst for Med Ed&Res, North Massapequa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Capital Cardiology Associates, Albany
- Velocity Clinical Research, Syracuse, East Syracuse
- NYC Research, New York
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Rochester Clinical Research - Buffalo, Buffalo
- CHEAR Center LLC, The Bronx
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Binghamton, Binghamton
- Hudson Valley Cardiovascular Practice PC, Poughkeepsie
- Rochester Clinical Research, Rochester
- and 2 more
RecruitingPhase 3
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Albany Medical College Committee of Research Involving Human Subjects, Albany
- SUNY Downstate Medical Center Brooklyn, Brooklyn
- Mattoo & Bhat Medical Associates, P.C., College Point
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Albany
- Research Site, Albany
- Research Site, Brooklyn
- and 12 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357Pelacarsen Roll-over Extension Program
- Jamaica Hospital Medical Center, Richmond Hill
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198The Prevent Coronary Artery Disease Trial
- Mount Sinai Fuster Heart Hospital, New York
RecruitingPhase 3
Ages 30 to 50 · All sexes · Updated Apr 29, 2025 · NCT06494501From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.